CEO Andrew Witty says the consumer business GSK is forming through brand divestitures and its JV with Novartis is a part of “the company I've been trying to create for seven years.” GSK’s OTC Flonase reached U.S. stores Feb. 3, a sign of additional product launches he expects the consumer health JV to do.

CEO Andrew Witty says the consumer business GSK is forming through brand divestitures and its JV with Novartis is a part of “the company I've been trying to create for seven years.” GSK’s OTC Flonase reached U.S. stores Feb. 3, a sign of additional product launches he expects the consumer health JV to do.

Bausch & Lomb has initiated a permanent, worldwide recall of ReNu with MoistureLoc, the company announces May 15. Months of investigation have turned up no definitive answers as to why use of the product is causing Fusarium keratitis, a potentially blinding fungal infection, leading CEO Ron Zarrella to conclude that a 'perfect storm' occurs when the product usage encounters "certain environmental conditions, lens-wear care practices, and other factors." The CDC's Morbidity & Mortality Weekly Report issued May 19 affirms that the MoistureLoc formulation was the only ReNu product with a statistically significant association with reporsts of Rusarium Keratitis, the company notes. Sales of the product in 2005 totaled about $100 mil. The company is recommending its Renu Multiplus and ReNu Multi-Purpose as replacement solutions...